 Arcutis Biotherapeutics, Inc. NASDAQ:ARQT Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Eric McIntyre - Head, IR Todd Watanabe - President, CEO Director Kenneth Lock - Chief Commercial Officer Patrick Burnett - SVP Chief Medical Officer Scott Burrows - CFO Principal Accounting Officer Conference Call Participants Kenneth Cacciatore - Cowen Vikram Purohit - Morgan Stanley Louise Chen - Cantor Fitzgerald Serge Belanger - Needham Company Seamus Fernandez - Guggenheim Securities Gregory Fraser - Truist Securities Uy Ear - Mizuho Group Operator Good day, and thank you for standing by. Welcome to the Arcutis Biotherapeutics, Inc. Q3 2022 Earnings Conference Call. 